Healthpeak Properties Inc DOC.N, DOC is expected to show a rise in quarterly revenue when it reports results on February 3 for the period ending December 31 2024
The Denver Colorado-based company is expected to report a 24.3% increase in revenue to $688.457 million from $553.65 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data. (SAL represents Property/Total Revenue)
LSEG's mean analyst estimate for Healthpeak Properties Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Healthpeak Properties Inc is $25.00, above its last closing price of $20.66.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.44 | 0.44 | 0.45 | Beat | 1.9 |
Jun. 30 2024 | 0.44 | 0.44 | 0.45 | Beat | 3 |
Mar. 31 2024 | 0.44 | 0.44 | 0.45 | Beat | 2.7 |
Dec. 31 2023 | 0.45 | 0.45 | 0.46 | Beat | 2.5 |
Sep. 30 2023 | 0.44 | 0.44 | 0.45 | Beat | 2.1 |
Jun. 30 2023 | 0.44 | 0.43 | 0.45 | Beat | 3.8 |
Mar. 31 2023 | 0.41 | 0.42 | 0.42 | Met | 0.7 |
Dec. 31 2022 | 0.43 | 0.43 | 0.35 | Missed | -19 |
This summary was machine generated January 31 at 21:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。